Andersen Eric's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Dec 11, 2023
- Accession no.
- 0000950170-23-069397
- Filed
- Dec 11, 2023, 4:05 PM ET
- Trade date
- Dec 7, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | PPurchaseAcquired | +76,384 | $12.85 | +$981,519.12 | 1,735,600 | Indirect | |
| Dec 7, 2023 | Common Stock | PPurchaseAcquired | +24,666 | $12.85 | +$316,953.17 | 484,458 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.